OTCQX:MRVFF - Post by User
Comment by
consultant99on Jun 20, 2017 2:26pm
376 Views
Post# 26383681
RE:June Investor Presentation
RE:June Investor PresentationLess than a week later since my last post and CTX continues to make new lows with the combined enterprise value since the spin-off now down by (26.6)%.
Pharma as a manufacturing business has but one simple objective - keep the plant running. SInce I haven't heard of any other drug manufacturers shutting down because they had not installed new equipment to serialize bottles (have you?) is it not logical to assume that management dropped the ball on this one?
Another traunch of options were issued this year to management...
Nuvo is an amazing company to work for because compensation is not performance based.
That is why management continues to get paid regardless of the loss in market cap, shareholder value, the continuing failure of clinical trials (two WF10 and two P2%) and now the spin-off.
Promoting Jessie on the pretext of bringing a number of deals to the table was misleading to one shareholder - ME!
The BOD has failed in its duty in my humble opinion and should resign.